Atara shares drop after larger Q3 loss than expected
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Atara treatment nears European approval
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Atara announces plan to cut workforce by 20%
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Atara reports Q1 loss as it pursues EU and FDA approvals
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sale of Atara’s Thousand Oaks property will fund company’s drug development through 2023
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
In Thousand Oaks, biotech execs discuss industry’s ‘rising tide,’ lament area’s lack of housing
In a dark period for the Ventura County economy, immediately before and during the COVID-19 pandemic, the biotechnology sector in the Conejo Valley has been a bright spot. The sector has grown in jobs, economic output and new businesses since 2019, even when the county as a whole has not, according to data presented on Read More →
Atara closes $100M sale of Thousand Oaks facility
Atara Biotherapeutics, a drugmaker based in South San Francisco with a large presence in Thousand Oaks, announced April 4 that its cell therapy manufacturing facility in Thousand Oaks was purchased by Fujifilm Corp. for $100 million. The deal was first announced in January and is part of a long-term strategic supply agreement between Atara and Read More →
